Top compounds associated with response to OR4C3


Feature Type Standardized
Nominal ANOVA
mRNA CAY10603 GDSC1000 pan-cancer AAC 0.035 0.2
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.038 0.2
mRNA masitinib GDSC1000 pan-cancer AAC 0.037 0.2
mRNA necrostatin-1 CTRPv2 pan-cancer AAC 0.042 0.2
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.04 0.2
mRNA neratinib CTRPv2 pan-cancer AAC -0.04 0.2
mRNA Irinotecan gCSI pan-cancer AAC -0.058 0.2
mRNA ATRA GDSC1000 pan-cancer AAC 0.039 0.2
mRNA YM201636 GDSC1000 pan-cancer AAC 0.036 0.3
mRNA KU 0060648 CTRPv2 pan-cancer AAC -0.04 0.3
Download CSV